Shares of Indian insurance companies, particularly those involved in distribution, experienced a significant downturn following the Insurance Regulatory and Development Authority of India's (IRDAI) proposed new regulations. The draft rules aim to cap commissions and reduce expenses of management (EoM), leading to worries about the profitability of insurance aggregators and other distributors. PB Fintech, the parent company of Policybazaar, was particularly hard hit, with Bernstein analysts describing the proposed commission cuts as "ugly" and warning that PB Fintech's unit economics would "unravel at proposed take-rate caps." Jefferies estimates that a 10% cut in new business commission rates could lead to a 10-12% fall in earnings for companies like PB Fintech and Turtlemint, with proposed cuts in health, term, and motor insurance ranging from one-third to one-half.
The IRDAI's motivation for these changes stems from a reform in 2023 that, while intended to give insurers flexibility, led to distributor remuneration growing significantly faster than premium income. Between FY23 and FY25, distributor payouts in general insurance rose 82% against 24-26% premium growth, and first-year payouts in life insurance increased 48-52% compared to 11-12% premium growth. This resulted in a larger share of premium income being absorbed by commissions, making insurance less affordable and potentially leading to misselling and policy churn due to high upfront commissions. The regulator's proposals seek to standardize commissions based on product complexity and improve transparency.
The proposed regulations include reducing the segment-level cap on EoM for general insurers from 30% to 20% over five years, and for life insurers to 10% over the same period. Commission caps are expected to vary by distribution channel, with individual agents potentially being least affected, followed by agencies, while banks and non-banking financial companies (NBFCs) could face the highest impact. Insurers heavily reliant on bancassurance might be more exposed. However, some insurers, like LIC and SBI Life, are expected to be less impacted due to their cost structures, product mix, and reliance on agency forces, which are favored by the new cap structure that rewards selling effort over distribution leverage.
While the industry is expected to push back against these proposals, analysts believe that the near-term price action will reflect the pain. Bernstein expects some of the lower costs to be passed on to customers, potentially driving a slight increase in volume, but is skeptical that this will fully offset the reduction in commission-driven sales. The draft also suggests potential drags in health and term insurance growth for insurers due to the caps. These regulatory changes underscore the IRDAI's broader objective of reducing distribution costs and making insurance more accessible and affordable for policyholders, while also addressing issues of regulatory arbitrage and misselling within the industry.
